Prescription Required.Why?
A sulfonylurea drug that stimulates the pancreas to release more insulin.
A biguanide that improves insulin sensitivity and reduces glucose production by the liver.
An alpha-glucosidase inhibitor that slows down the absorption of carbohydrates in the gut.
Type 2 diabetes mellitus, particularly when diet and exercise alone are insufficient to control blood sugar levels.
Used in patients who require the combined effects of three different mechanisms of action to achieve optimal glycemic control.
This triple combination medication works synergistically to manage blood sugar. Glimepiride increases insulin release, metformin enhances insulin sensitivity and reduces hepatic glucose production, and voglibose slows carbohydrate digestion and absorption. This combined action leads to improved glucose control.
Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children. Discard any unused medication after the expiry date.
Dosage should be determined by a healthcare professional based on individual needs and response.
Start with the lowest effective dose and gradually increase as needed, guided by regular blood glucose monitoring.
Always take the medication as prescribed. Do not skip doses or change your dosage without consulting your doctor.
Hypoglycemia (low blood sugar): Symptoms include sweating, shakiness, dizziness, and confusion.
Lactic acidosis (rare but serious): Characterized by muscle pain, fatigue, and shortness of breath.
Gastrointestinal issues: Nausea, vomiting, diarrhea, abdominal pain, and bloating.
Weight gain
Allergic reactions: Skin rash, itching, hives.
Alcohol can increase the risk of hypoglycemia and should be consumed moderately or avoided, especially with this medication.
Hypoglycemia can impair alertness and reaction time. Avoid driving or operating machinery if experiencing symptoms of low blood sugar.
Not recommended during pregnancy and breastfeeding. Consult your doctor for alternative management options.
Not typically used in children. Dosage and safety in this population are not well-established.
Renal function should be monitored, as metformin can accumulate in patients with impaired kidney function.
Liver function should be monitored, as liver impairment can affect metabolism of the medication.
Please consult your physician or pharmacist for detailed information and references specific to your prescription and health status.
